Gabelli Funds’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-151,503
Closed -$2.83M 1458
2022
Q1
$2.83M Buy
151,503
+45,900
+43% +$826K 0.02% 635
2021
Q4
$2.26M Buy
+105,603
New +$2.08M 0.01% 701

Other funds holding OCDX

Gabelli Funds's OCDX Position: Q2 2022 in Review

Gabelli Funds sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 151,503 shares — an estimated $2.83M sold.

Gabelli Funds first reported a position in OCDX in Q4 2021 and held it in 2 quarters. The position peaked at $2.83M in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

  • Gabelli Funds reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
  • Gabelli Funds sold 151,503 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $2.83M.
  • Gabelli Funds first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q4 2021 and held it in 2 quarters.
  • Gabelli Funds's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $2.83M in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Gabelli Funds's 13F filing for Q2 2022, filed 12 Aug 2022.